Investment companies
7 hours ago • minute(s) readAuthor Sparks Team
HgCapital Trust (HGT); plans to invest £31.6m in Argus Media
Argus Media is a leading global provider of energy and commodity price reporting.Hg, the Manager of HgCapital Trust announced that it plans to invest in Argus Media. HgCapital Trust will invest approximately £31.6m in Argus, with other institutional clients of Hg investing alongside the company through the Hg Saturn Fund.
Healthcare
7 hours ago • minute(s) readAuthor Sparks Team
Shield Therapeutics (STX); present positive results
Shield Therapeutics announced that the positive results for Feraccru/Accrufer (Ferric Maltol) in AEGIS-H2H phase 3b non-inferiority study will be presented at the 27th United European Gastroenterology Week (UEG) 2019.
Metals & mining
21-10-2019 08:12:33 • minute(s) readAuthor Sparks Team
KEFI Minerals (KEFI); allots and issues 23,732,031 new shares
KEFI has received notice from one of its working capital providers to convert £150,000 of the loan note issued on 5 August 2019 and associated costs of £7,500 into new KEFI ordinary shares of 0.1p each at a price 0.664p per share. Therefore, KEFI has allotted and issued 23,732,031 new KEFI ordinary shares of 0.1p each to the loan facility provider.
Healthcare
21-10-2019 08:09:49 • minute(s) readAuthor Sparks Team
Avacta Group (AVCT); interim results report revenues at £4.1m
The company announced a fundraising to raise gross proceeds of up to £9mAvacta Group announced its interim results for the period ended 31 July 2019. Revenues of £4.1m were greater than expected due to recognition of an up-front milestone payment of $2.5m from LG Chem Life Sciences. Operating loss was £11.2m due to significant investment in research and development.
Healthcare
18-10-2019 08:12:26 • minute(s) readAuthor Sparks Team
Tissue Regenix Group (TRX); expects a reduction in margin-impacting EBITDA
emand for the company's products remained strongIn its trading update, Tissue Regenix Group announced that it anticipates revenue for 2019 to be below the current market consensus by nearly 15–20%, with a corresponding reduction in margin-impacting EBITDA. The company expects the increase in throughput to become available during Q4 2019.
TMT
18-10-2019 08:05:51 • minute(s) readAuthor Sparks Team
discoverIE Group (DSCV); announces placing of shares by Peel Hunt
discoverIE announced that Peel Hunt has placed a total of 8,034,840 new ordinary shares of 5p each in the share capital of the company at a price of 415p per placing share, raising gross proceeds of c. £33m.
Consumer
17-10-2019 08:01:12 • minute(s) readRecord plc (REC ); release positive trading update
Record’s Q220 update is positive, showing assets under management equivalent (AUME) up 2.7% to $59.9bn (+6.1% in sterling terms). The AUME flow was a positive $1.7bn after a modest $0.3bn inflow in Q1. Market movements (+$1.3bn) and exchange rate and mandate volatility targeting movements (-$1.4bn) broadly balanced each other. Most of the AUME inflow was in passive hedging and reflected increased mandates from existing clients (tending to validate Record’s focus on service enhancement and innovation).
Industrials
17-10-2019 08:00:31 • minute(s) readAuthor Sparks Team
Norcros (NXR); trading update: expects group revenue for H1 at £181.2m
Norcros provided a trading update for the 27-week period ended 6 October 2019.The company expects group revenue for the period to be approximately £181.2m (2018: £162.6m), which is 11.4% higher than the prior year 26-week period on a reported basis, 12.8% higher on a constant currency basis, and 0.9% higher on a like-for-like constant currency basis.
Investment companies
17-10-2019 07:59:27 • 1 minute(s) readAuthor Sparks Team
Fidelity Special Values (FSV); issues 625,000 new ordinary shares
Following the issue, the company has gained the authority to issue 17,919,440 more sharesFidelity Special Values has issued 625,000 new ordinary shares of 5p each at a price of 264.25p per share from its block listing authority of 15 January 2019. The shares will rank pari passu with the existing ordinary shares in issue.
Healthcare
16-10-2019 08:21:13 • minute(s) readAuthor Sparks Team
Destiny Pharma (DEST); positive phase 1 results published
Headline results continue to be expected in mid-2020The company notes the publication of results from a positive phase 1 clinical study in 60 healthy US volunteers using a nasal gel formulation of its lead drug, XF-73 (exeporfinium chloride) in the peer reviewed Journal of Global Antimicrobial Resistance.
Financials & real estate
16-10-2019 07:47:03 • minute(s) readSecure Trust Bank (STB); release trading update in reassuring tone
Secure Trust Bank released its trading update for Q319 with a reassuring tone. The business trends and “overall results are in line with management expectations”. They noted that demand has slacked in September, but not a surprise given Brexit deadline concerns. STB has in a re-risking mode for several quarters and has been repositioning its loan book in anticipation to these economic and political uncertainties. In this context, it is reassuring to see that the bank say that it “remains comfortable with guidance for the full year”.
Investment companies
14-10-2019 08:08:50 • minute(s) readAuthor Sparks Team
Aberdeen New Thai IT (ANW); report NAV total return at 14.6%
Aberdeen New Thai Investment Trust announced its half-yearly financial report for the six months ending 31 August 2019. NAV per ordinary share increased 12.8% to 723.37p. Revenue return was 15.8p per share, while net gearing stood at 3.5%.
TMT
14-10-2019 08:06:57 • minute(s) readAuthor Sparks Team
SCISYS Group (SSY); wins a contract to support Defra
SCISYS announced that it has been selected by Shearwell Data to provide IT services, project management, integration and maintenance of software in Defra’s innovative Livestock Information Programme (LIP). The contract provides an option to extend it to 2024.
TMT
14-10-2019 08:05:58 • minute(s) readAuthor Sparks Team
ReNeuron Group (RENE); reports positive efficacy data in retinal disease
Study investigator presents positive efficacy data in ongoing retinal disease clinical trial.
ReNeuron Group announced that positive efficacy data was presented at the American Academy of Ophthalmology Annual Meeting (AAO) in San Francisco from the company’s Phase 1/2a clinical trial of its hRPC stem cell therapy in retinitis pigmentosa (RP).
TMT
11-10-2019 07:25:36 • minute(s) readAuthor Sparks Team
YouGov (YOU); employee benefit trust purchases 1,000,000 ordinary shares
YouGov announced that Sanne Fiduciary Services, acting as Trustee of the YouGov Employee Benefit Trust (EBT), has purchased a total of 1,000,000 ordinary shares of 0.2p each in the group as part of a planned programme over a 10 month period.
Consumer
11-10-2019 07:25:32 • minute(s) readAuthor Sparks Team
Entertainment One (ETO); reports group underlying EBITDA of £13.4m
Entertainment One announced its first quarter results (unaudited) for the three months ended 30 June 2019. The value of the group’s library assets increased to $2.1bn as at 31 March 2019. The quarterly results were prepared in relation to the proposed acquisition of the group by Hasbro (previously reported on 22 August 2019).
Did you know ...
400+
companies covered across 40+ countries
450+
press mentions last year
30+
events per year
2500+
reports published per year